Sentiment Trading

SelectQuote Inc.’s stock price surged on strong Q4 earnings and revenue growth, but the company faces ongoing legal challenges that may impact investor confidence.

SelectQuote Inc. reports mixed Q3 2025 results, with 41% growth in SelectRx membership, but a cautious outlook and financial challenges, including a negative P/E ratio, raise concerns about the company’s future prospects.

SelectQuote Inc. is facing legal challenges and a decline in stock value due to allegations of Medicare kickbacks and a False Claims Act complaint filed by the US Department of Justice.